The Focal One System Precisely Destroys Prostatic Lesions With Less Risk of Side Effects
The Department of Urology at Hackensack University Medical Center now offers advanced non-invasive treatment options for patients with localized prostate cancer.
Focal One is an advanced robotic high-intensity focused ultrasound (HIFU) system that enables urologists at Hackensack University Medical Center to use sound waves to precisely target and destroy diseased prostate tissue. is. Surgery to remove the prostate and radiation therapy.
Focal One combines real-time ultrasound image guidance and magnetic resonance imaging
(MRI) and biopsy data are used to create a 3D image of the targeted treatment area. Using a small probe inserted into the rectum, urologists use 3D image guidance to navigate to the tumor and direct high-speed ultrasound energy to the target area to resect or destroy just the diseased portion of the prostate. To do. No incision required. .
The combination of these technologies will allow urologists to improve accuracy, destroy tumors with less damage to surrounding healthy tissue, and minimize the risk of side effects associated with radical prostatectomy and radiation therapy. I can.
The addition of Focal One builds on urology’s reputation for leading-edge multidisciplinary care. For the past 15 years, Kevin Basralian, MD, a urologist at Hackensack University Medical Center, has traveled the world, including the Bahamas, Switzerland, and Canada, where the technology has been approved for years, to help diagnose prostate cancer. Went for his HIFU surgery. New Jersey’s best doctors to perform HIFU procedures.
Dr. Basralian is also participating in a study on HIFU for prostate cancer, working to raise awareness of focused therapy as an option for patients.
“I have patients who want a second or third opinion, but they don’t know that topical therapy is an option,” Dr. Basralian said. “The Focal One machine is phenomenal and the treatment is unparalleled.
“Dr. Basralian’s extensive experience with HIFU and the acquisition of the Focal One system has enabled advanced non-incision prostate cancer treatment delivered by an expert urologist here in New Jersey without the need to travel far from home.” We can now provide patient access to treatment.” Michael D. Stifelman, MD, Chief of Urology at Hackensack University Medical Center and Director of Robotic Surgery at Hackensack Meridian health, and Professor and Chair of the Department of Urology at Hackensack Meridian Medical College. “We are proud to be at the forefront of urological cancer treatment and research, and offering the non-invasive He Focal One HIFU treatment represents the next frontier in prostate cancer treatment. .”